S1PR2 mutational inactivation or deletion confers proliferative advantage in diffuse large B-cell lymphoma (DLBCL) cell lines in vitro and in vivo mouse models [132]. The gene discussed is S1PR2; the disease is diffuse large B-cell lymphoma.